High-fat diet alters gene expression in the liver and colon: Links to increased development of aberrant crypt foci

Digestive Diseases and Sciences

Volumn 57, Issue 7, 2012, Pages 1866-1874

  Padidar, Sara ^a   Farquharson, Andrew J ^a   Williams, Lynda M ^a   Kearney, Rebecca ^a   Arthur, John R ^a   Drew, Janice E ^a  

^a ROWETT RESEARCH INSTITUTE   (United Kingdom)

Author keywords

Colon cancer; Leptin; Obesity related cancer Gene expression

Indexed keywords

AZOXYMETHANE; CYTOCHROME P450 2E1; CYTOKINE; INTERLEUKIN 6; LEPTIN; LEPTIN RECEPTOR;

ABERRANT CRYPT FOCUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASCENDING COLON; BODY COMPOSITION; BODY WEIGHT; CELL PROLIFERATION; COLON; COLON CANCER; CONTROLLED STUDY; DESCENDING COLON; DOWN REGULATION; GENE EXPRESSION; LIPID DIET; LIVER; LOW FAT DIET; MARKER GENE; MOUSE; NONHUMAN; OBESITY; PRECANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEM CELL; UPREGULATION; XENOBIOTIC METABOLISM;

ABERRANT CRYPT FOCI; ANIMALS; BODY COMPOSITION; COLON; COLORECTAL NEOPLASMS; CYTOCHROME P-450 CYP2E1; CYTOKINES; DIET, HIGH-FAT; DIETARY FATS; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; INCIDENCE; LEPTIN; LIVER; MICE; MICE, INBRED C57BL; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, LEPTIN;

EID: 84864279981     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/s10620-012-2092-9     Document Type: Article

References (36)

1. World Cancer Research Fund/American Institute for Cancer Research. Food Nutrition, Physical Activity, and the Prevention of Cancer: A Global Perspective. Washington, DC: AICR; 2007.
2. Harriss DJ, Atkinson G, George K, et al. Lifestyle factors and colorectal cancer risk: systematic review and meta-analysis of associations with body mass index. Colorectal Dis. 2009;11: 547-563.
3. Koda M, Sulkowska M, Kanczuga-Koda L, Surmacz E, Sulkowski S. Overexpression of the obesity hormone leptin in human colorectal cancer. J Clin Pathol. 2007;60:902-906. (Pubitemid 47234437)
4. Karmiris K, Koutroubakis IE, Xidakis C, Ploychronaki M, Voudouri T, Kouroumalis EA. Circulating levels of leptin, adiponectin, resi-stin, and ghrelin in inflammatory bowel disease. Inflamm Bowel Dis. 2006;12:100-105.
5. Sitaraman S, Liu X, Charrier L, et al. Colonic leptin: source of a novel proinflammatory cytokine involved in IBD. FASEB J. 2004;18:696-698.
6. Drew JE. Molecular mechanisms linking adipokines to obesityrelated colon cancer: focus on leptin. Proc Nutr Soc. 2011;71: 175-180.
7. Bahceci M, Tuzcu A, Akkus M, Yaldiz M, Ozbay A. The effect of high-fat diet on the development of obesity and serum leptin levels in rats. Eat Weight Disord. 1999;4:128-132.
8. Kowalska I, Straczkowski M, Kinalska I. The effect of fasting and physical exercise on plasma leptin concentrations in high-fat-fed rats. J Physiol Pharmacol. 1999;50:309-320. (Pubitemid 29321161)
9. Fenton JI, Hord NG, Lavigne JA, Perkins SN, Hursting SD. Leptin, insulin-like growth factor-1, and insulin-like growth factor-2 are mitogens in ApcMin/+ but not Apc+/+ colonic epithelial cell lines. Cancer Epidemiol Biomarkers Prev. 2005;14:1646-1652. (Pubitemid 40995074)
10. Ohba S, Lanigan TM, Roessler BJ. Leptin receptor JAK2/STAT3 signalling modulates expression of Frizzled receptors in articular chondrocytes. Osteoarthr Cartil. 2010;18:1620-1629.
11. Wang L, Shao YY, Ballock RT. Leptin synergizes with thyroid hormone signalling in promoting growth plate chondrocyte proliferation and terminal differentiation in vitro. Bone. 2011;48: 1022-1027.
12. Cottrell S, Bicknell D, Kaklamanis L, Bodmer WF. Molecular analysis of APC mutations in familial adenomatous polyposis and sporadic colon carcinomas. Lancet. 1992;340:626-630.
13. Fantuzzi G, Faggioni R. Leptin in the regulation of immunity, inflammation, and hematopoiesis. J Leukoc Biol. 2000;68: 437-446.
14. Padidar S, Farquharson AJ, Williams LM, et al. Leptin upregulates pro-inflammatory cytokines in discrete cells within mouse colon. J Cell Physiol. 2011;56:1028-1036.
15. Padidar S, Farquharson AJ, Williams LM, et al. Leptin-induced changes in protein expression in mouse colon. Dig Dis Sci. 2011;56:1028-1036.
16. Aparicio T, Kotelevets L, Tsocas A, et al. Leptin stimulates the proliferation of human colon cancer cells in vitro but does not promote the growthofcolon cancer xenografts innude miceorintestinal tumorigenesis in ApcMin/+ mice. Gut. 2005;54:1136-1145. (Pubitemid 41025909)
17. Aparicio T, Guilmeau S, Goiot H, et al. Leptin reduces the development of the initial precancerous lesions induced by azoxymethane in the rat colonic mucosa. Gastroenterology. 2007;126:449-510.
18. Bird RP. Role of aberrant crypt foci in understanding the pathogenesis of colon cancer. Cancer Lett. 1995;93:55-71.
19. Ealey KN, Lu S, Archer MC. Development of aberrant crypt foci in the colons of ob/ob and db/db mice: evidence that leptin is not a promoter. Mol Carcinog. 2008;47:667-677.
20. Lin S, Thomas TC, Storlien LH, Huang XF. Development of high-fat diet-induced obesity and leptin resistance in C57Bl/6 mice. Int J Obes Relat Metab Disord. 2000;24:639-646. (Pubitemid 30323498)
21. Leclercq IA, Field J, Enriquez A, Farrell GC, Robertson GR. Constitutive and inducible expression of hepatic CYP2E1 in leptin-deficient ob/ob mice. Biochem Biophys Res Commun. 2000;268:337-344. (Pubitemid 30119623)
22. Sohn OS, Fiala ES, Requeijo SP, Weisburger JH, Gonzalez FJ. Differential effects of CYP2E1 status on the metabolic activation of the colon carcinogens azoxymethane and methylazoxymethanol. Cancer Res. 2001;61:8435-8440. (Pubitemid 33131121)
23. Chen J, Huang X. The signal pathways in azoxymethane-induced colon cancer and preventive implications. Cancer Biol Ther. 2009; 8:4-8.
24. Drew JE, Farquharson AJ, Padidar S, et al. Insulin, leptin and adiponectin receptors in colon: regulation relative to differing body adiposity independent of diet and in response to dimethylhydrazine. Am J Physiol GI Liver. 2007;293:G682-G691. (Pubitemid 47605924)
25. Reddy BS. Dietary fat and colon cancer: animal model studies. Lipids. 1992;27:807-813.
26. Reddy BS, Tanaka T, Simi B. Effect of different levels of dietary trans fat or corn oil on azoxymethane-induced colon carcinogenesis in F344 rats. J Natl Cancer Inst. 1985;75:791-798. (Pubitemid 16222409)
27. Sinha R, Cross AJ, Graubard BI, Leitzmann MF, Schatzkin A. Meat intake and mortality: a prospective study of over half a million people. Arch Intern Med. 2009;169:562.
28. Le Marchand L, Donlon T, Seifried A, Wilkens LR. Red meat intake, CYP2E1 genetic polymorphisms, and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev. 2002;11:1019-1024. (Pubitemid 35192652)
29. Morita M, Le Marchand L, Kono S, et al. Genetic polymorphisms of CYP2E1 and risk of colorectal cancer: the Fukuoka colorectal cancer study. Cancer Epidemiol Biomarkers Prev. 2009;18:235.
30. Thörn M, Finnström N, Lundgren S, Rane A, Lööf L. Cytochromes P450 and MDR1 mRNA expression along the human gastrointestinal tract. Brit J Clin Pharmacol. 2005;60:54-60. (Pubitemid 40942781)
31. Thelen K, Dressman JB. Cytochrome P450-mediated metabolism in the human gut wall. J Pharm Pharmacol. 2009;61:541-558.
32. Atreya R, Neurath MF. Involvement of IL-6 in the pathogenesis of inflammatory bowel disease and colon cancer. Clin Rev Allergy Immunol. 2005;28:187-196.
33. Rose-John S, Mitsuyama K, Matsumoto S, Thaiss WM, Scheller J. Interleukin-6 trans-signalling and colonic cancer associated with inflammatory bowel disease. Curr Pharm Des. 2009;15: 2095-2103.
34. Drew JE, Mayer C-D, Farquharson AJ, Young P, Barrera LN. Custom design of a GeXP multiplexed assay used to assess expression profiles of inflammatory gene targets in colon normal, polyp and tumour tissue. J Mol Diag. 2011;13:233-242.
35. Drew JE, Farquharson AJ, Keijer J, Barrera LN. Complex regulation of mucosal pentraxin (Mptx) revealed by discrete micro-anatomical locations in colon. Biochim Biophys Acta Mol Basis Dis. 2006;1762:844-848. (Pubitemid 44429942)
36. Barker N, van Es JH, Kuipers J, et al. Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature. 2007; 449:1003-1007. (Pubitemid 350014593)